Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for performing antisense oligonucleotide-mediated exon skipping in the retina of a subject in need thereof

Methods for performing antisense oligonucleotide-mediated exon skipping in the retina of a subject in need thereof

US Patent 11667913 · Granted Jun 6, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment and prediction of therapeutic responses in patients suffering from Fri2024
Methods for the treatment of Leber congenital amaurosis2022
Methods for the treatment of Leber congenital amaurosis2022
Methods for the treatment of Leber congenital amaurosis2022
Methods for the treatment of Leber congenital amaurosis2022
Antagonist of the fibroblast growth factor receptor 3 (FGFR3) for use in the tre2022
Methods for the treatment of Leber congenital amaurosis2020
Methods for the treatment of Leber congenital amaurosis2020
Methods for the treatment of Leber congenital amaurosis2020
Methods for the treatment of Leber congenital amaurosis2020
Antagonist of the fibroblast growth factor receptor 3 (FGFR3) for use in the tre2018
Methods for the treatment and diagnosis of bone mineral density related diseases2017